LeonaBio, Inc. (LONA)
NASDAQ: LONA · Real-Time Price · USD
7.69
-0.02 (-0.19%)
At close: Aug 21, 2026, 4:00 PM EDT
7.63
-0.06 (-0.78%)
After-hours: Aug 21, 2026, 7:30 PM EDT
LeonaBio Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 32.32 | 69.28 | 48.44 | 90.58 | 95.97 | 110.54 |
Short-Term Investments | 18.74 | 19.06 | 2.84 | 56.84 | 104.38 | 143.22 |
Cash & Short-Term Investments | 51.07 | 88.33 | 51.28 | 147.42 | 200.34 | 253.76 |
Cash Growth | 71.23% | 72.27% | -65.22% | -26.42% | -21.05% | 37.40% |
Accounts Receivable | - | - | - | - | 1.23 | 2.34 |
Other Receivables | - | - | - | 1.63 | - | - |
Receivables | - | - | - | 1.63 | 1.23 | 2.34 |
Prepaid Expenses | 3.74 | 1.13 | 3.57 | 5.68 | 5.96 | 4.7 |
Total Current Assets | 54.81 | 89.46 | 54.84 | 154.73 | 207.53 | 260.8 |
Property, Plant & Equipment | 1.4 | 2.01 | 3.25 | 4.44 | 5.32 | 5.22 |
Long-Term Investments | - | - | - | - | 44.83 | 65.94 |
Other Long-Term Assets | 0.69 | 0.69 | 0.69 | 1.08 | 0.48 | 0.06 |
Total Assets | 56.89 | 92.15 | 58.78 | 160.25 | 258.15 | 332.01 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 2.42 | 4.59 | 0.32 | 0.13 | 2.5 | 0.57 |
Accrued Expenses | 4.91 | 4.96 | 12.4 | 28.34 | 18.6 | 8.44 |
Current Portion of Leases | 0.49 | 0.47 | 0.41 | 0.37 | 0.33 | 0.29 |
Other Current Liabilities | - | 37.49 | - | - | - | - |
Total Current Liabilities | 7.82 | 47.5 | 13.14 | 28.84 | 21.43 | 9.29 |
Long-Term Leases | 0.09 | 0.34 | 0.8 | 1.22 | 1.59 | 1.63 |
Other Long-Term Liabilities | 15.4 | 16.52 | - | - | - | - |
Total Liabilities | 23.3 | 64.36 | 13.94 | 30.06 | 23.02 | 10.92 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0 | 0 | - | 0 | 0 | 0 |
Additional Paid-In Capital | 597.31 | 539.55 | 450.99 | 439.74 | 428.62 | 417.36 |
Retained Earnings | -563.71 | -511.76 | -406.15 | -309.21 | -191.53 | -95.9 |
Comprehensive Income & Other | -0.01 | -0 | 0 | -0.35 | -1.96 | -0.39 |
Total Common Equity | 33.6 | 27.79 | 44.84 | 130.19 | 235.14 | 321.08 |
Shareholders' Equity | 33.6 | 27.79 | 44.84 | 130.19 | 235.14 | 321.08 |
Total Liabilities & Equity | 56.89 | 92.15 | 58.78 | 160.25 | 258.15 | 332.01 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 0.58 | 0.8 | 1.22 | 1.59 | 1.91 | 1.92 |
Net Cash (Debt) | 50.49 | 87.53 | 50.06 | 145.83 | 198.43 | 251.84 |
Net Cash Growth | 75.28% | 74.85% | -65.67% | -26.51% | -21.21% | 37.11% |
Net Cash Per Share | 3.88 | 20.47 | 13.01 | 38.36 | 52.59 | 68.21 |
Filing Date Shares Outstanding | 9.42 | 9.39 | 3.9 | 3.83 | 3.79 | 3.76 |
Total Common Shares Outstanding | 9.42 | 9.34 | 3.9 | 3.82 | 3.79 | 3.74 |
Working Capital | 46.99 | 41.96 | 41.71 | 125.89 | 186.1 | 251.51 |
Book Value Per Share | 3.57 | 2.98 | 11.49 | 34.11 | 62.08 | 85.90 |
Tangible Book Value | 33.6 | 27.79 | 44.84 | 130.19 | 235.14 | 321.08 |
Tangible Book Value Per Share | 3.57 | 2.98 | 11.49 | 34.11 | 62.08 | 85.90 |
Machinery | - | 1.42 | 1.42 | 1.4 | 1.13 | 0.59 |
Construction In Progress | - | - | - | - | - | 1.12 |
Leasehold Improvements | - | 4.32 | 4.32 | 4.32 | 4.3 | 2.56 |